Assignee
IOVANCE BIOTHERAPEUTICS INC
US·106 granted patents·75 pending applications·1,361 citations·filing 2017–2025
Top patents by PatentIndex Score
181 records- 0199US11998568B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2022·Granted Jun 4, 2024·4 cites·23 claims
- 0299US11541077B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2022·Granted Jan 3, 2023·21 cites·24 claims
- 0399US11529372B1Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2022·Granted Dec 20, 2022·20 cites·23 claims
- 0499US11517592B1Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2022·Granted Dec 6, 2022·20 cites·27 claims
- 0599US11344579B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted May 31, 2022·11 cites·20 claims
- 0699US11337998B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted May 24, 2022·6 cites·19 claims
- 0799US11304979B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Apr 19, 2022·6 cites·19 claims
- 0899US11291687B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Apr 5, 2022·6 cites·16 claims
- 0999US11273180B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Mar 15, 2022·6 cites·19 claims
- 1099US11273181B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Mar 15, 2022·7 cites·19 claims
- 1199US11241456B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Feb 8, 2022·7 cites·20 claims
- 1299US11202803B1Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Dec 21, 2021·6 cites·20 claims
- 1399US11202804B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Dec 21, 2021·7 cites·20 claims
- 1499US11083752B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2020·Granted Aug 10, 2021·22 cites·20 claims
- 1599US11052115B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2020·Granted Jul 6, 2021·12 cites·22 claims
- 1699US11052116B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2020·Granted Jul 6, 2021·13 cites·24 claims
- 1799US11040070B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Jun 22, 2021·13 cites·14 claims
- 1899US11013770B1Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted May 25, 2021·28 cites·24 claims
- 1999US11007225B1Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2020·Granted May 18, 2021·7 cites·29 claims
- 2099US11007226B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2020·Granted May 18, 2021·13 cites·20 claims
- 2199US10953046B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2020·Granted Mar 23, 2021·28 cites·25 claims
- 2299US10953047B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2020·Granted Mar 23, 2021·28 cites·26 claims
- 2399US10946044B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2020·Granted Mar 16, 2021·28 cites·15 claims
- 2499US10946045B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2020·Granted Mar 16, 2021·28 cites·15 claims
- 2599US10933094B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2020·Granted Mar 2, 2021·28 cites·26 claims
- 2699US10925900B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2020·Granted Feb 23, 2021·19 cites·15 claims
- 2799US10905718B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2020·Granted Feb 2, 2021·25 cites·24 claims
- 2899US10894063B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2018·Granted Jan 19, 2021·26 cites·46 claims
- 2999US10695372B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2019·Granted Jun 30, 2020·17 cites·15 claims
- 3099US10653723B1Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2020·Granted May 19, 2020·32 cites·30 claims
- 3199US10646517B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2019·Granted May 12, 2020·17 cites·23 claims
- 3299US10639330B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2019·Granted May 5, 2020·17 cites·11 claims
- 3399US10537595B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2018·Granted Jan 21, 2020·35 cites·22 claims
- 3499US10463697B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2018·Granted Nov 5, 2019·22 cites·21 claims
- 3599US10420799B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2018·Granted Sep 24, 2019·26 cites·11 claims
- 3699US10398734B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2018·Granted Sep 3, 2019·25 cites·15 claims
- 3799US10363273B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2018·Granted Jul 30, 2019·50 cites·29 claims
- 3899US10272113B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2018·Granted Apr 30, 2019·37 cites·23 claims
- 3999US10166257B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2018·Granted Jan 1, 2019·48 cites·20 claims
- 4099US10130659B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2018·Granted Nov 20, 2018·55 cites·29 claims
- 4198US12485145B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2024·Granted Dec 2, 2025·1 cites·21 claims
- 4298US12194061B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2022·Granted Jan 14, 2025·2 cites·22 claims
- 4398US11819517B2Methods of using tumor infiltrating lymphocytes in double-refractory melanomaIOVANCE BIOTHERAPEUTICS INC·Filed 2018·Granted Nov 21, 2023·18 cites·15 claims
- 4498US11433097B2Methods of using tumor infiltrating lymphocytes in double-refractory melanomaIOVANCE BIOTHERAPEUTICS INC·Filed 2018·Granted Sep 6, 2022·25 cites·23 claims
- 4598US11369637B2Restimulation of cryopreserved tumor infiltrating lymphocytesIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Jun 28, 2022·6 cites·25 claims
- 4698US11364266B2Restimulation of cryopreserved tumor infiltrating lymphocytesIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Jun 21, 2022·6 cites·25 claims
- 4798US11351199B2Restimulation of cryopreserved tumor infiltrating lymphocytesIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Jun 7, 2022·6 cites·25 claims
- 4898US11351197B2Restimulation of cryopreserved tumor infiltrating lymphocytesIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Jun 7, 2022·5 cites·20 claims
- 4998US11351198B2Restimulation of cryopreserved tumor infiltrating lymphocytesIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Jun 7, 2022·19 cites·20 claims
- 5098US11344580B2Restimulation of cryopreserved tumor infiltrating lymphocytesIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted May 31, 2022·5 cites·20 claims
Showing the top 50 of 181 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →